Differential effects of tumor necrosis factor-alpha co-administered with amyloid beta-peptide (25-35) on memory function and hippocampal damage in rat

Behavioural Brain Research

Volumn 175, Issue 2, 2006, Pages 352-361

  Stepanichev, Mikhail ^a   Zdobnova, Irina ^a   Zarubenko, Irina ^a   Lazareva, Natalia ^a   Gulyaeva, Natalia V ^a  

^a INSTITUTE OF HIGHER NERVOUS ACTIVITY AND NEUROPHYSIOLOGY   (Russian Federation)

Author keywords

Alzheimer's disease; Amyloid peptide 25 35; Inflammation; Learning; Memory; Neurodegeneration; Tumor necrosis factor

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIOR DISORDER; BEHAVIORAL SCIENCE; BRAIN DAMAGE; BRAIN NERVE CELL; BRAIN REGION; CELL LOSS; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; HIPPOCAMPUS; HISTOLOGY; LEARNING DISORDER; MALE; MAZE TEST; MEMORY; MEMORY CONSOLIDATION; MEMORY DISORDER; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; RAT; TASK PERFORMANCE; TRAINING; WORKING MEMORY;

AMYLOID BETA-PROTEIN; ANALYSIS OF VARIANCE; ANIMALS; AVOIDANCE LEARNING; DRUG INTERACTIONS; EXPLORATORY BEHAVIOR; HIPPOCAMPUS; INFLAMMATION; INJECTIONS, INTRAVENTRICULAR; MALE; MAZE LEARNING; MEMORY; NERVE DEGENERATION; NEURONS; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; STATISTICS, NONPARAMETRIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33750996735     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2006.09.006     Document Type: Article

References (65)

1. Abercrombie M. Estimation of nuclear population from microtome sections. Anatom Rec 94 (1946) 239-247
2. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., et al., Neuroinflammation Working Group. Inflammation and Alzheimer's disease. Neurobiol Aging 21 (2000) 383-421
3. Araujo D.M., and Cotman C.W. Beta-amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease. Brain Res 569 (1992) 141-145
4. 2+ accumulation. Proc Natl Acad Sci USA 92 (1995) 9328-9332
5. Blasko I., Schmitt T.L., Steiner E., Trieb K., and Grubeck-Loebenstein B. Tumor necrosis factor α augments amyloid β protein (25-35) induced apoptosis in human cells. Neurosci Lett 238 (1997) 17-20
6. Behl C., Davis J., Lesley R., and Schubert D. Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77 (1994) 817-827
7. Bjugstad K.B., Flitter W.D., Garland W.A., Su G.C., and Arendash G.W. Preventive actions of a synthetic antioxidant in a novel animal model of AIDS dementia. Brain Res 795 1-2 (1998) 349-357
8. Butterfield D.A., Koppal T., Subramaniam R., and Yatin S. Vitamin E as an antioxidant/free radical scavenger against amyloid beta-peptide-induced oxidative stress in neocortical synaptosomal membranes and hippocampal neurones in culture: insights into Alzheimer's disease. Rev Neurosci 10 (1999) 141-149
9. Cheng B., Christakos S., and Mattson M.P. TNFs protects neurons against excitotoxic/metabolic insults, and promote maintenance of calcium homeostasis. Neuron 12 (1994) 139-153
10. Chung J.A., and Cummings J.L. Neurobehavioral and neuropsychiatric symptoms in Alzheimer's disease. Neurol Clin 18 (2000) 829-846
11. Combs C.K., Kario J.C., Kao S.-C., and Landreth G.E. β-Amyloid stimulation of microglia and monocytes results in TNFα-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J Neurosci 21 (2001) 1179-1188
12. Daffner K.R., Scinto L.F.M., Weintraub S., Guinessey J.E., and Mesulam M.M. Diminished curiosity in patients with probable Alzheimer's disease as measured by exploratory eye movements. Neurology 42 (1992) 320-328
13. Delobette S., Privat A., and Maurice T. In vitro aggregation facilities beta-amyloid peptide-(25-35)-induced amnesia in the rat. Eur J Pharmacol 319 (1997) 1-4
14. Gathan E., and Overmeier J.B. Inflammatory pathogenesis in Alzheimer's disease: biological mechanisms and cognitive sequeli. Neurosci Biobehav Rev 23 (1999) 615-633
15. Gathan E., and Overmeier J.B. Performance more than working memory disrupted by acute systemic inflammation in rats in appetitive tasks. Physiol Behav 73 (2001) 201-210
16. Giovannelli L., Casamenti F., Scali C., Bartolini L., and Pepeu G. Differential effects of amyloid peptides β-(1-40) and β-(25-35) injections into the rat nucleus basalis. Neuroscience 66 (1995) 781-792
17. Hajeer A.H., and Hutchinson I.V. TNFα gene polymorphism: clinical, and biological implications. Microsc Res Technol 50 (2000) 216-228
18. Hanisch U.-K. Microglia as a source and target of cytokines. Glia 40 (2002) 140-155
19. Harkany T., Mulder J., Sasvan M., Abraham I., Konya C., Zarandi M., et al. N-Methyl-d-aspartate receptor antagonist MK-801 and radical scavengers protect cholinergic nucleus basalis neurons against β-amyloid neurotoxicity. Neurobiol Dis 6 (1999) 109-121
20. Harwood D.G., Sultzer D.L., and Wheatley M.V. Impaired insight in Alzheimer disease: association with cognitive deficits, psychiatric symptoms and behavioral disturbances. Neuropsychiatry Neuropsychol Behav Neurol 13 (2000) 83-88
21. Hauss-Wegrzyniak B., Dobrzanski P., Stoer J.D., and Wenk G.L. Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease. Brain Res 780 (1998) 294-303
22. Hsu H., Xiong J., and Goeddel D.V. The TNF receptor 1-associated protein TRADD signals cell death, and NF-kappa B activation. Cell 81 (1995) 495-504
23. Ivins K.J., Ivins J.K., Sharp J., and Cotman C.W. Multiple pathways of apoptosis in PC12 cells. CrmA inhibits apoptosis induced by β-amyloid. J Biol Chem 274 (1999) 2107-2112
24. 26]β-amyloid 1-40 to toxic and proteinase-resistant fragments. Neuroscience 104 (2001) 1003-1011
25. Kar S., Slowikowski S.P., Westaway D., and Mount H.T. Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer's disease. J Psychiatry Neurosci 29 (2004) 427-441
26. Kiyota Y., Miyamoto M., and Nagaoka A. Relationship between brain damage and memory impairment in rats exposed to transient ischemia. Brain Res 538 (1991) 295-302
27. 26]Aβ25-35/40) and fragment presence in the brains of Alzheimer's patients. J Neurosci Res 70 (2002) 474-483
28. 695SWE mutation: effects on exploratory activity, anxiety, and motor coordination. Brain Res 977 (2003) 38-45
29. Loddick S.A., and Rothwell N.J. Mechanisms of tumor necrosis factor α action on neurodegeneration: interaction with insulin-like growth factor-1. Proc Natl Acad Sci USA 96 (1999) 9449-9451
30. Lue L.F., Rydel R., Brigham E.F., Yang L.B., Hampel H., Murphy Jr. J.M., et al. Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro. Glia 35 (2001) 72-79
31. Matsumoto Y., Watanabe S., Suh Y.H., and Yamamoto T. Effects of intrahippocampal CT105, a carboxyl terminal fragment of beta-amyloid precursor protein, alone/with inflammatory cytokines on working memory in rats. J Neurochem 82 (2002) 234-239
32. Mattson M.P., Goodman Y., Luo H., Fu W., and Furukawa K. Activation of NF-κB protects hippocampal neurons against oxidative stress-induced apoptosis: evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration. J Neurosci Res 49 (1997) 681-697
33. Maurice T., Lockhart B.P., and Privat A. Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction. Brain Res 706 (1996) 181-193
34. McGeer P.L., and McGeer E.G. Inflammation, autotoxicity and Alzheimer disease. Neurobiol Aging 22 (2001) 799-809
35. Meda L., Baron P., and Scarlato G. Glial activation in Alzheimer's disease: the role of Aβ and its associated proteins. Neurobiol Aging 22 (2001) 885-893
36. Meda L., Cassatella M.A., Szendrei G.T., Otvos L., Baron P., Villalba M., et al. Activation of microglial cells by β-amyloid protein and interferon γ. Nature 374 (1995) 647-650
37. Miguel-Hidalgo J.J., and Casabelos R. beta-Amyloid (1-40)-induced neurodegeneration in the rat hippocampal neurons of the CA1 subfield. Acta Neuropathol 95 (1998) 455-465
38. Miranda S., Opazo C., Larrondo L.F., Munoz F.J., Ruiz F., Leighton F., et al. The role of oxidative stress in the toxicity induced by amyloid β-peptide in Alzheimer's disease. Progr Neurobiol 62 (2000) 633-648
39. Mosconi L. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imaging 32 (2005) 486-510
40. Nomura J., Hosoi T., Okuma Y., and Nomura Y. Aβ-induced expression and acetylcholine action in mouse glial cells. Life Sci 72 (2003) 2117-2120
41. Olariu A., Tran M.H., Yamada K., Mizuno M., Hefco V., and Nabeshima T. Memory deficits and increased emotionality induced by β-amyloid (25-35) are correlated with the reduced acetylcholine release and altered phorbol dibutyrate binding in the hippocampus. J Neural Transm 108 (2001) 1065-1079
42. O'Mahony S.O., Harkany T., Rensink A.A.M., Abraham I., De Jong G.I., Varga J.L., et al. Beta-amyloid-induced cholinergic denervation correlates with enhanced nitric oxide synthase activity in rat cerebral cortex: reversal by NMDA receptor blockade. Brain Res Bull 45 (1998) 405-411
43. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1982), Academic Press, Sydney 321 pp.
44. Perry R.T., Collins J.S., Wiener H., Acton R., and Go R.C.P. The role of TNF and its receptors in Alzheimer's disease. Neurobiol Aging 22 (2001) 873-883
45. Peschon J.J., Torrance D.S., Stocking K.L., Glaccum M.B., Otten C., Willis C.R., et al. TNF receptor-deficient mice reveal divergent roles for p55, and p75 in several models of inflammation. J Immunol 160 (1998) 943-952
46. Riepe M.W. Cholinergic treatment: what are the early neuropathological targets?. Eur J Neurol Suppl 3 (2005) 3-9
47. Rossi F., and Bianchini E. Synergistic induction of nitric oxide and cytokines in astrocytes. Biochem Biophys Res Commun 225 (1996) 474-478
48. Rowan M.J., Klyubin I., Wang Q., and Anwyl R. Synaptic plasticity disruption by amyloid beta protein: modulation by potential Alzheimer's disease modifying therapies. Biochem Soc Trans 33 Pt 4 (2005) 563-567
49. Rozhnova U.A., Stepanichev M.Y., Korobko V.G., Gulyaeva N.V., and Alesenko A.V. Activation of sphingomyelin cycle and accumulation of cholesterol in cerebral cortex, hippocampus and cerebellum of rats induced by tumor necrosis factor alpha. Neurochemistry (Nejrokhimija Rus) 16 (1999) 302-309
50. Rusakov S.A., Filippova G.N., Pushkareva M.Y., Korobko V.G., and Alessenko A.V. Effect of tumour necrosis factor on the free sphingosine content and sphingomyelinase activity in mouse liver cells and nuclei. Biochemistry (Moscow) 58 (1993) 724-732
51. Sadowski M., Morys J., Barcikowska M., and Narkiewicz O. Astrocyte and microglia reaction in Alzheimer's disease in the hippocampal formation-a quantitative analysis. Alzheimer's Res 1 (1995) 71-76
52. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81 (2001) 741-766
53. Stepanichev M., Lazareva N.A., Onufriev M.V., Mitrokhina O.S., Moiseeva Y.V., and Gulyaeva N.V. The effect of the administration of beta-amyloid peptide fragment (25-35) on behavior in rats. Zh Vyssh Nerv Deiat 47 (1997) 597-600
54. Stepanichev M.Y., Moiseeva Y.V., Lazareva N.A., Onufriev M.V., and Gulyaeva N.V. Single intracerebroventricular administration of amyloid-beta (25-35) peptide induces impairment in short-term rather than long-term memory in rats. Brain Res Bull 61 (2003) 197-205
55. Stepanichev M.Y., Onufriev M.V., Mitrokhina O.S., Moiseeva Y.V., Lazareva N.A., Viktorov I.V., et al. Neurochemical, behavioral, and neuromorphological effects of central administration of beta-amyloid peptide (25-35) in rat. Neurochemistry (Nejrokhimija Rus) 17 (2000) 291-306
56. Stepanichev M.Y., Zdobnova I.M., Yakovlev A.A., Onufriev M.V., Lazareva N.V., Zarubenko I.I., et al. Effects of tumor necrosis factor-alpha central administration on hippocampal damage in rat induced by amyloid beta-peptide (25-35). J Neurosci Res 71 (2003) 110-120
57. Sun M.K., and Alkon D.L. Impairment of hippocampal CA1 heterosynaptic transformation and spatial memory by beta-amyloid(25-35). J Neurophysiol 87 (2002) 2441-2449
58. Szczepanik A.M., Rampe D., and Ringheim G.E. Amyloid-β peptide fragments p3 and p4 induce pro-inflammatory cytokine and chemokine production in vitro and in vivo. J Neurochem 77 (2001) 304-317
59. Tarkowski E., Liljeroth A.-M., Minthon L., Tarkowski A., Wallin A., and Blennow K. Cerebral pattern of pro- and anti-inflammatory cytokines in dementias. Brain Res Bull 61 (2003) 255-260
60. Vitkovic L., Bockaert J., and Jacque C. "Inflammatory" cytokines: neuromodulators in normal brain?. J Neurochem 74 (2000) 457-471
61. Weldon D.T., Rogers S.D., Ghilardi J.R., Finke M.P., Cleary J.P., O'Hare E., et al. Fibrillar β-amyloid induced microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of select population of neurons in the rat CNS in vivo. J Neurosci 18 (1998) 2161-2173
62. Yamaguchi Y., and Kawashima S. Effects of amyloid-β-(25-35) on passive avoidance, radial-arm maze learning and choline acetyltransferase activity in the rat. Eur J Pharmacol 412 (2001) 265-272
63. Yan Z., and Feng J. Alzheimer's disease: interactions between cholinergic functions and beta-amyloid. Curr Alzheimer Res 1 (2004) 241-248
64. Yankner B.A. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16 (1996) 921-932
65. Yankner B.A., Duffy L.K., and Kirshner D.A. Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science 250 (1990) 279-282